|
1
|
Frangogiannis NG: Cardiac fibrosis: Cell
biological mechanisms, molecular pathways and therapeutic
opportunities. Mol Aspects Med. 65:70–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prabhu SD and Frangogiannis NG: The
Biological Basis for Cardiac Repair After Myocardial Infarction:
From Inflammation to Fibrosis. Circ Res. 119:91–112. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma ZG, Yuan YP, Wu HM, Zhang X and Tang
QZ: Cardiac fibrosis: New insights into the pathogenesis. Int J
Biol Sci. 14:1645–1657. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Humeres C and Frangogiannis NG:
Fibroblasts in the Infarcted, Remodeling, and Failing Heart. JACC
Basic Transl Sci. 4:449–467. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji Y, Qiu M, Shen Y, Gao L, Wang Y, Sun W,
Li X, Lu Y and Kong X: MicroRNA-327 regulates cardiac hypertrophy
and fibrosis induced by pressure overload. Int J Mol Med.
41:1909–1916. 2018.PubMed/NCBI
|
|
6
|
Kong P, Christia P and Frangogiannis NG:
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci.
71:549–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weber KT: Fibrosis in hypertensive heart
disease: Focus on cardiac fibroblasts. J Hypertens. 22:47–50. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Frangogiannis NG: Cardiac fibrosis: Cell
biological mechanisms, molecular pathways and therapeutic
opportunities. Mol Aspects Med. 65:70–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma H, Kong J, Wang YL, Li JL, Hei NH, Cao
XR, Yang JJ, Yan WJ, Liang WJ, Dai HY and Dong B:
Angiotensin-converting enzyme 2 overexpression protects against
doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.
Oncotarget. 8:24548–24563. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen T, Li M, Fan X, Cheng J and Wang L:
Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II–Induced
Differentiation of Human Atrial Fibroblasts into Myofibroblasts.
Oxid Med Cell Longev. 2018:67125852018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong X, Yu S, Wang Y, Yang M, Xiong J, Hei
N, Dong B, Su Q and Chen J: (Pro)renin receptor-mediated myocardial
injury, apoptosis, and inflammatory response in rats with diabetic
cardiomyopathy. J Biol Chem. 294:8218–8226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li R, Xiao J, Qing X, Xing J, Xia Y, Qi J,
Liu X, Zhang S, Sheng X, Zhang X, et al: Sp1 Mediates a Therapeutic
Role of MiR-7a/b in Angiotensin II–Induced Cardiac Fibrosis via
Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac
Fibroblasts. PLoS One. 10:e01255132015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Działo E, Tkacz K and Błyszczuk P:
Crosstalk between the TGF-β and WNT signalling pathways during
cardiac fibrogenesis. Acta Biochim Pol. 65:341–349. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang
WF and Zhou L: Angiotensin II increases CTGF expression via
MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Exp Cell Res.
318:2105–2115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trial J and Cieslik KA: Changes in cardiac
resident fibroblast physiology and phenotype in aging. Am J Physiol
Heart Circ Physiol. 315:H745–H755. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rane CK and Minden A: P21 activated kinase
signaling in cancer. Semin Cancer Biol. 54:40–49. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun X, Su VL and Calderwood DA: The
subcellular localization of type I p21-activated kinases is
controlled by the disordered variable region and polybasic
sequences. J Biol Chem. 294:14319–14332. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rudolph J, Crawford JJ, Hoeflich KP and
Wang W: Inhibitors of p21-activated kinases (PAKs). J Med Chem.
58:111–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Wang S, Lei M, Boyett M, Tsui H,
Liu W and Wang X: The p21-activated kinase 1 (Pak1) signalling
pathway in cardiac disease: From mechanistic study to therapeutic
exploration. Br J Pharmacol. 175:1362–1374. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Al-Azayzih A, Gao F and Somanath PR: P21
activated kinase-1 mediates transforming growth factor β1-induced
prostate cancer cell epithelial to mesenchymal transition. Biochim
Biophys Acta. 1853:1229–1239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY,
Hu HZ, Wu YQ, Song J, Yan J and Wu LJ: Silencing of Rac1 modifies
lung cancer cell migration, invasion and actin cytoskeleton
rearrangements and enhances chemosensitivity to antitumor drugs.
Int J Mol Med. 28:769–776. 2011.PubMed/NCBI
|
|
22
|
Yang Y, Du J, Hu Z, Liu J, Tian Y, Zhu Y,
Wang L and Gu L: Activation of Rac1-PI3K/Akt is required for
epidermal growth factor-induced PAK1 activation and cell migration
in MDA-MB-231 breast cancer cells. J Biomed Res. 25:237–245. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang C, Lee HJ, Shrivastava A, Wang R,
McQuiston TJ, Challberg SS, Pollok BA and Wang T: Long-Term In
Vitro Expansion of Epithelial Stem Cells Enabled by Pharmacological
Inhibition of PAK1-ROCK-Myosin II and TGF-β Signaling. Cell Rep.
25:598–610.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu W, Zi M, Naumann R, Ulm S, Jin J,
Taglieri DM, Prehar S, Gui J, Tsui H, Xiao RP, et al: Pak1 as a
novel therapeutic target for antihypertrophic treatment in the
heart. Circulation. 124:2702–2715. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Buttke TM, McCubrey JA and Owen TC: Use of
an aqueous soluble tetrazolium/formazan assay to measure viability
and proliferation of lymphokine-dependent cell lines. J Immunol
Methods. 157:233–240. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mazzei M, Vascellari M, Zanardello C,
Melchiotti E, Vannini S, Forzan M, Marchetti V, Albanese F and
Abramo F: Quantitative real time polymerase chain reaction
(qRT-PCR) and RNAscope in situ hybridization (RNA-ISH) as effective
tools to diagnose feline herpesvirus-1-associated dermatitis. Vet
Dermatol. 30:491–e147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Talman V and Ruskoaho H: Cardiac fibrosis
in myocardial infarction-from repair and remodeling to
regeneration. Cell Tissue Res. 365:563–581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Holtz J: Pathophysiology of heart failure
and the renin-angiotensin-system. Basic Res Cardiol. 88 (Suppl
1):183–201. 1993.PubMed/NCBI
|
|
29
|
Petrov VV, Fagard RH and Lijnen PJ:
Stimulation of collagen production by transforming growth
factor-beta1 during differentiation of cardiac fibroblasts to
myofibroblasts. Hypertension. 39:258–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Harada M, Luo X, Qi XY, Tadevosyan A,
Maguy A, Ordog B, Ledoux J, Kato T, Naud P, Voigt N, et al:
Transient receptor potential canonical-3 channel-dependent
fibroblast regulation in atrial fibrillation. Circulation.
126:2051–2064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Alex L and Frangogiannis NG: The Cellular
Origin of Activated Fibroblasts in the Infarcted and Remodeling
Myocardium. Circ Res. 122:540–542. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hirsch AT, Pinto YM, Schunkert H and Dzau
VJ: Potential role of the tissue renin-angiotensin system in the
pathophysiology of congestive heart failure. Am J Cardiol.
66:D22–D332. 1990. View Article : Google Scholar
|
|
33
|
Sabapathy K, Hochedlinger K, Nam SY, Bauer
A, Karin M and Wagner EF: Distinct roles for JNK1 and JNK2 in
regulating JNK activity and c-Jun-dependent cell proliferation. Mol
Cell. 15:713–725. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Harms FL, Kloth K, Bley A, Denecke J,
Santer R, Lessel D, Hempel M and Kutsche K: Activating Mutations in
PAK1, Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental
Disorder. Am J Hum Genet. 103:579–591. 2018. View Article : Google Scholar : PubMed/NCBI
|
